AstraZeneca confirms talks with biotech group Acerta
14th Dec 2015 08:14
(ShareCast News) - Pharmaceuticals giant AstraZeneca confirmed that it is exploring potential strategic options with biotech company Acerta Pharma BV. "There can be no certainty that any transaction will ultimately be entered into, or as to the terms of any transaction," AZN said. The statement fol
Read moreBroker tips: IAG, BHP Billiton, AstraZeneca, GSK
2nd Dec 2015 13:11
(ShareCast News) - Clear skies lie ahead for the European Airlines sector going into the winter trading period, thanks to a favourable outlook for capacity growth and given the considerable fall in oil prices since August 2015, Nomura said. The global macroeconomic outlook, notably in the core UK an
Read moreAstraZeneca rallies on double upgrade from Morgan Stanley
2nd Dec 2015 10:00
(ShareCast News) - Pharmaceutical stocks got a boost on Wednesday as Morgan Stanley double upgraded AstraZeneca to 'overweight' from 'underweight' and said it was among its top picks. The bank, which lifted AZN's target price to 5,300p from 4,300p, said it has underperformed dramatically over the pa
Read moreAstraZeneca and Sanofi agree to share chemical compounds
20th Nov 2015 09:29
(ShareCast News) - French and British pharmaceutical giants Sanofi and AstraZeneca have agreed a direct exchange of 210,000 compounds from their respective, proprietary compound libraries. The companies said on Friday that the deal would enhance the chemical diversity of the compound collections and
Read moreFTSE 100 movers: AstraZeneca rival's failure helps boost market
16th Nov 2015 15:12
(ShareCast News) - The FTSE 100 remained resilient after Friday night's terrorist attacks in Paris, with the market up 3.02 points (0.05%) to 6,121.30 points mid-afternoon Monday. AstraZeneca was the market's biggest riser after news that the US Food and Drug Administration has asked for additional
Read moreClovis Oncology tanks as FDA asks for more drug data; AstraZeneca gets a boost
16th Nov 2015 14:28
(ShareCast News) - Shares in Clovis Oncology tanked on Monday after it said the US Food and Drug Administration has requested additional clinical data on the efficacy of its experimental lung cancer drug, rociletinib. The Colorado-based company said it expects the review of this additional informati
Read moreFriday newspaper share tips: Sell as Amec Foster Wheeler faces more pain
6th Nov 2015 11:43
(ShareCast News) - Traders should sell shares in Amec Foster Wheeler as the company prepares for the long haul, according to The Telegraph's Questor. The oil and gas engineering services company announced on Thursday it was cutting its dividend by half and lifting its cost-savings target from £120m
Read moreLondon open: All eyes trained on October US jobs report
6th Nov 2015 08:31
(ShareCast News) - Investors stuck to the sidelines ahead of what some analysts believed would be a make-or-break jobs report for market expectations of a rate hike by the US central bank in December. Ahead of those numbers, as of 0839 GMT the FTSE 100 was advancing by 7.28 points to 6,372.28. The S
Read moreLondon pre-open: October US jobs report may hold key to December FOMC
6th Nov 2015 07:47
(ShareCast News) - In Friday´s session all eyes will be trained on the latest US jobs report for October, which may hold the key to an interest rate hike - or not - at the 15-16 December meeting of the US Federal Open Market Committee. Is the outlook for the American economy so strong that beginning
Read moreLondon close: Copper prices weigh on Footsie despite dovish MPC
5th Nov 2015 16:36
(ShareCast News) - Equities ended near their worst levels of the day despite a dovish set of minutes from the Bank of England's last Monetary Policy Committee meeting, weighed down by a further drop in commodity prices. Following its meeting, the MPC said there were downside risks to growth
Read moreFTSE 100 movers: Anglo American falls to 16-year lows
5th Nov 2015 14:18
(ShareCast News) - The FTSE 100 was down for most of the day on Thursday, with the market going into the black briefly after the Bank of England kept interest rates unchanged. By mid-afternoon, the market was back into the red, down 22.58 points (0.35%) to 6,390.3 points. Anglo American was the big
Read moreLondon open: Investors anxious ahead of MPC's 'Super Thursday'
5th Nov 2015 08:30
(ShareCast News) - Investors in UK shares were anxious ahead of Thursday's meeting of the Monetary Policy Committee after remarks by US Federal Reserve chairwoman Janet Yellen on the previous day led traders to push up the odds of a December rate hike across the Pond. As of 0945 GMT the FTSE 100 was
Read moreAstraZeneca's third quarter profit hit by foreign exchange
5th Nov 2015 07:11
(ShareCast News) - AstraZeneca's third quarter revenues have been hit by foreign exchange woes, but the company has upgraded its revenue outlook for the year and beat expectations for earnings per share. The FTSE 100 pharmaceutical company posted its third quarter results to 30 September on Thursday
Read moreLondon pre-open: MPC, central banks in focus
5th Nov 2015 07:07
(ShareCast News) - Investors were anxious ahead of Thursday´s meeting of the Monetary Policy Committee given the more 'hawkish' tone adopted by US Federal Reserve chairwoman Janet Yellen on the previous day. The Footsie was being called to start the day 11 points above Wednesday´s close of 6,412.88
Read moreAstraZeneca's gout drug recommended by FDA committee
26th Oct 2015 07:18
(ShareCast News) - The US Food and Drug Administration's Arthritis Advisory Committee has recommended the approval of AstraZeneca's lesinurad tablets for the treatment of hyperuricemia associated with gout. The FTSE 100 drug company announced the decision on Monday. The committee recommended the dr
Read more